Definitive Healthcare Corp. (NASDAQ:DH) Q1 2023 Earnings Conference Call May 4, 2023 5:00 PM ET
Company Participants
Matt Ruderman – Chief Legal Officer
Robert Musslewhite – Chief Executive Officer
Jason Krantz – Founder and Executive Chairman
Rick Booth – Chief Financial Officer
Conference Call Participants
Jared Haase – William Blair
Matt Shea – Needham & Co.
Craig Hettenbach – Morgan Stanley
Joe Vruwink – Baird
David Grossman – Stifel
Allen Lutz – Bank of America
Johnathan McCary – Raymond James
Jonathan Yong – Credit Suisse
Operator
Greetings and welcome to the Definitive Healthcare First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Matt Ruderman. Thank you, Matt. You may begin.
Matt Ruderman
Good afternoon and thank you for joining us today to review Definitive Healthcare’s quarterly financial results. Joining me on the call today are Robert Musslewhite, CEO; Jason Krantz, Founder and Executive Chairman; and Rick Booth, CFO.
During this call, we will make forward-looking statements including but not limited to, statements related to our market and future performance and growth opportunities, the benefits of our Healthcare Commercial Intelligence Solutions, our competitive position, customer behaviors, our financial guidance, our planned investments and the anticipated impacts of global macroeconomic conditions on our business, results and clients and on the healthcare industry generally.
Any forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve a number of risks and uncertainties, including those discussed in the risk factor sections and elsewhere in our filings with the SEC. Actual results may differ materially from any forward-looking statements. The company undertakes no obligation to revise or update any forward-looking statements to reflect events that may arise after this conference call except as required by law.
For more information, please refer to the cautionary statement included in the earnings release that we have just posted to the Investor Relations portion of our website. Additionally, we will discuss non-GAAP financial measures on this conference call. Please refer to the tables in our earnings release on the Investor Relations portion of our website for reconciliation of these measures to their most directly comparable GAAP financial measure.
With that, I’d like to turn the call over to Robert.